0001507673-20-000002.txt : 20200214
0001507673-20-000002.hdr.sgml : 20200214
20200213191450
ACCESSION NUMBER: 0001507673-20-000002
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20191231
FILED AS OF DATE: 20200214
DATE AS OF CHANGE: 20200213
EFFECTIVENESS DATE: 20200214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: RP Management, LLC
CENTRAL INDEX KEY: 0001507673
IRS NUMBER: 611450238
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-19261
FILM NUMBER: 20612889
BUSINESS ADDRESS:
STREET 1: 110 EAST 59TH STREET
STREET 2: SUITE 3300
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-883-0200
MAIL ADDRESS:
STREET 1: 110 EAST 59TH STREET
STREET 2: SUITE 3300
CITY: NEW YORK
STATE: NY
ZIP: 10022
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001507673
XXXXXXXX
12-31-2019
12-31-2019
RP Management, LLC
110 East 59th Street
Suite 3300
New York
NY
10022
13F HOLDINGS REPORT
028-19261
N
Jason Mehar
Vice President, Investments & Deputy General Counsel
2128832271
/s/ Jason Mehar
New York
NY
02-13-2020
1
6
442294
false
1
0001507678
028-19630
Legorreta Pablo G.
INFORMATION TABLE
2
a13f2019q4draftinformation.xml
INFORMATION TABLE
CYTOKINETICS INC
COM NEW
23282W605
9291
875656
SH
DFND
1
875656
0
0
IMMUNOMEDICS INC
COM
452907108
92536
4373178
SH
DFND
1
4373178
0
0
BIOHAVEN PHARMACTL HLDG CO L
COM
G11196105
114923
2111111
SH
DFND
1
2111111
0
0
SUNESIS PHARMACEUTICALS INC
COM
867328700
44
129517
SH
DFND
1
129517
0
0
EPIZYME INC
COM
29428V104
164000
6666667
SH
DFND
1
6666667
0
0
EPIZYME INC
COM
29428V904
61500
2500000
SH
Call
DFND
1
2500000
0
0